Glucocorticoids regulate the expression of the gene for atrial natriuretic peptide (ANP) in neonatal cardiocytes. Dexamethasone 
Introduction
Atrial natriuretic peptide (ANP)' is a hormone that possesses significant activity in the cardiovascular, renal and endocrine systems. It has potent smooth muscle relaxant (1) and natriuretic (2) activity, and it suppresses the secretion of renin (3) , vasopressin (4) , and aldosterone (5, 6) , three hormones that 1. Abbreviations used in this paper: ANP, atrial natriuretic peptide; BUdR, bromodeoxyuridine; Dex, dexamethasone; DOCA, deoxycorticosterone acetate; GRE, glucocorticoid responsive elements. function to maintain intravascular volume. The bioactive peptide appears to be derived from the carboxyterminus of a much larger precursor molecule whose structure has recently been elucidated through the cloning ofthe ANP cDNA (7) (8) (9) (10) . The genes for human (11) (12) (13) , mouse (13) , and rat (14) ANP have been cloned and sequenced. Noteworthy, within the second intron of both the rat and human gene there are short stretches of DNA that bear some homology to the consensus sequence of the so-called glucocorticoid regulatory elements (15) (16) (17) , raising the intriguing possibility that the genes for ANP might be regulated by steroid hormones.
Glucocorticoids have recently been shown to increase circulating levels of ANP in the rat (21, 22) . Glucocorticoids administered in vivo also increase the levels ofANP mRNA in atrial and extraatrial tissues (22, 23) . The present study demonstrates that these effects take place directly at the level ofthe ANP-producing cell. Glucocorticoids increase ANP secretion, ANP mRNA levels, and relative transcription rates ofthe ANP gene in primary cultures of rat cardiocytes, suggesting that glucocorticoids directly regulate the expression of this gene.
Methods
Restriction enzymes, SI nuclease, and calf intestinal alkaline phosphate were purchased from Bethesda Research Laboratories (Gaithersburg, MD) or Boehringer-Mannheim (Indianapolis, IN).
[a32p]-Deoxyribonucleotides and [3H]uridine were obtained from Amersham Corp., Arlington Heights, IL; [y32P]ATP was purchased from ICN Pharmaceuticals (Cleveland, OH). The rat ANP gene was supplied to us as a 4.2-kb Eco RI fragment subcloned in pBR322 by Dr. B. Greenberg, while recombinant human pro-ANP was generously provided to us by Dr. R. Scarborough ofCalifornia Biotechnology, Inc. (Mountain View, CA). RU 38486 was a gift of Roussel Pharmaceuticals (Romaineville, France). Other reagents were purchased from standard commercial suppliers and represent the best grades commercially available.
Cell preparation. Neonatal cardiocytes were prepared using a modification of the procedure described by Simpson and Savion (24) . In brief, 1-d-old rat pups were killed and intact hearts, including atria, were excised using sterile technique. Cells were dispersed using alternating cycles of trypsin (0.1%) digestion and mechanical disruption (trituration through a 10-ml wide bore pipette (Falcon Labware, Oxnard, CA). After removal of tissue debris (Cellector filter, 30 mesh; Belco, Vineland, NJ), the cells were pooled and preplated for 30 min to allow for attachment of nonmyocardial cells to the tissue culture plate (24) . Myocardial cells were decanted from the plate, plated in DME H2 1 medium containing 10% FCS and 0.1 mM bromodeoxyuridine (BUdR; to suppress fibroblast growth) for 48 h. Based on immunofluo-point the media was replaced with fresh deinduction media, with or without the addition of exogenous hormone as dictated by the experimental protocol. Steroids were dissolved in 0.1% ethanol; 0.1% ethanol was added to all control cells.
To generate enriched preparations of atrial or ventricular cells, intact neonatal hearts were divided slightly below the atrioventricular groove. The lower portion, devoid of atrial tissue was used to generate the ventricular cardiocyte preparation. The upper portion of the heart (3 30% of the total mass) was digested independently to generate an atrial cardiocyte-enriched preparation. To generate the nonmyocardial cell cultures cells collected on the dish surface during the preplating step (see above) were allowed to divide in culture for = 3 wk. This procedure enriched the preparation for nonmyocardial cellular elements by effectively diluting out residual myocardial cells as a function oftime in culture. These cells were split into small dishes and treated as were the cardiocytes above except that BUdR was excluded from the media.
Isolation ofRNA. SI nuctease and blot-hybridization analysis. SI nuclease analysis was carried out as described previously (27) using an 840-bp Eco RIBgl II fragment that spans the 5'-end of the rat ANP gene (14) . Blot hybridization analysis was carried out using the technique of Thomas (28) . For dot-hybridization analysis the technique of Berents et al. (29) was employed. Hybridization was carried out with a rat ANP cDNA probe radiolabeled by nick translation. Relative ANP transcript levels were assessed by densitometric scanning ofthe major nuclease SI protected product (-195 nucleotides) or hybridizing dots on the autoradiographs. Differences were calculated using one-way analysis of variance and the Newman-Keuls test.
Radioimmunoassay and immunoprecipitation analysis. Radioimmunoassay of ANP was performed as described previously (27) . To avoid concerns about serum-mediated processing ofANP immunoreactivity secreted into the tissue culture media, totally defined serumfree media (25) was employed in these studies.
Aliquots of culture media were stored frozen at -20°C until assay. For radioimmunoassay Ml of media and 500 ,l of rabbit antisera Immunoprecipitation of ANP released into the culture media was carried out essentially as described by Bloch et al. (31) using an antiserum raised against thyroglobulin-coupled rat ANP. Myocardial cell cultures were pulsed for 2 h with ('5S]cysteine, at which point the label was removed. The media was collected after an additional 3-h incubation, immunoprecipitated, and analyzed by SDS-PAGE.
Run-on transcription assay. Neonatal cardiocytes (4 X 106 per plate), prepared as described above and maintained in deinduction medium for 72 h, were exposed to 1 uM Dex or fresh deinduction medium for S h at 370C. All subsequent procedures were performed at 0-40C. The incubation was terminated by washing and harvesting the cells in PBS. After centrifugation the cells were resuspended and washed in buffer (10 mM Tris.HCI pH 7.9, 10 mM NaCl, 6 mM MgCl2, 5 mM DTT). After repeat centrifugation the cells were lysed by vortexing in 1.5 ml ofthe same buffer containing 0.5% NP-40. After 10 min on ice and repeat vortexing the cells were further disrupted by 12 strokes with the A pestle in a Dounce homogenizer. Nuclei were collected by low speed centrifugation, washed with lysis buffer without NP-40, and, after repeat centrifugation, resuspended in 100 ul oftranscription buffer (50 mM Tris HCI pH 7.9, 100 mM KC1, 12.5% glycerol, 6 mM MgCl2, 1 mM MnC12, 0.2 mM EDTA, 20 mM NH4SO4, 6 mM NaF, 10IM creatine phosphate, 100 Mug/ml of creatine phosphokinase, 10 After incubation at 30°C for 30 min an equal volume of DNAse buffer (50 mM Tris * HCO pH 7.9,2mM CaC12, 5 mM MgCl2, 1 mg/ml yeast tRNA, 10 mM DTI, 2 U/Ml RNAsin) containing 100 Mg/ml (final concentration) RNAse-free DNAse (Cooper Biomedical, Malvern, PA) was added and the incubation continued for 15 min at 37°C. At that point an equal volume of2X PK buffer (200 mM Tris * HC1 pH 7.5, 25 mM EDTA, 300 mM NaCl, 1% SDS) plus 50 Mg/ml (final concentration) heat-treated proteinase K was added and the incubation continued for 45 min at 37°C. After extraction with phenol/chloroform, 32P-labeled RNA was further purified by the method of Matrisian et al. (32) . Radioactivity incorporated into RNA was monitored using DE ,ug/ml yeast tRNA and 50 ug/ml polyadenylic acid, the buffer was aspirated and the sections were covered with 20,ul ofbuffer containing the [3Hjradiolabeled rANP cRNA or mRNA probe (-100,000 cpm per slide) and topped with glass coverslips. Slides were incubated overnight at 45°C in a humidified environment. After posthybridization treatment with ribonuclease A (20 ,ug/ml at 37°C for 60 min), the unhybridized probe was removed by washing the sections in 0.2X SSC at 45°C with frequent changes of buffer. After washing, the slides were air dried and dipped in Ilford K5 photographic emulsion (diluted 1:1 in H20 at 37°C) in the darkroom. The slides were then air dried for 2 h in the dark and stored desiccated at 4°C. After 1 wk exposure, the slides were developed, dehydrated in graded alcohols and xylene, and mounted with Permount. The slides were counterstained with hematoxylin and examined under lightfield illumination in a Zeiss photomicroscope.
Results
As shown in Fig. 1 the major and minor ANP transcripts in neonatal cardiocytes appear to be very similar to those previously identified in mature adult atria (27) . The major transcripts protect a labeled fragment -190-195 nucleotides in length mapping their 5'-termini to a position -20-30 nucleotides downstream from the genomic TATAAAA sequence, which is thought to dictate the start site of transcription (14) . The minor transcripts map 10 and 80 nucleotides further upstream. In addition the overall size ofthe ANP transcript (950-1050 nucleotides, see below) is very similar to that previously reported in the mature atria (27) The glucocorticoid dexamethasone increased ANP mRNA levels in a dose-related fashion between l0-8 and 10-6 M Dex peaking at a level approximately six-fold above controls (a < 0.01; Fig. 1 Cardiocytes were deinduced in medium containing 5% serum substitute and 5% "stripped" serum (5/5) for 72 h then changed to 10% serum substitute (for measurement of ANP immunoreactivity) or fresh 5/5 medium (for measurement of ANP mRNA levels) in the presence of the additives indicated for 24 h. A I00-,u aliquot of media was taken for the RIA. Cytoplasmic RNA was collected and analyzed as described in
Methods. Results are expressed as mean±SD, n = 3 for RIA, n = 4 for RNA analyses. * a < 0.01 vs. Ctl; $ a < 0.05 vs. Dex 10-7 M; §a <0.01 vs. Dex 10-6 M.
script (950-1050 nucleotides) levels (Fig. 2) . RU 38486, a specific glucocorticoid antagonist, reduced both the increase in cellular ANP mRNA as well as the increase in secreted ANP protein seen after exposure to Dex (Table II) . Next, we attempted to determine whether Dex increased ANP mRNA levels through a transcriptional versus posttranscriptional mechanism. We approached this question first using the "run-on" transcription technique, an in vitro assay which provides a semiquantitative measure of RNA-polymerase II molecules actively involved in transcribing the ANP gene in nuclei exposed to hormone in vivo. As shown in Fig. 3 A Dex increased ANP gene transcription about twofold in nuclei from cells previously treated for 5 h with the steroid. We also assessed potential effects of Dex on ANP mRNA turnover (Fig. 3 B) using conventional pulse-chase analysis. Based on this approach, a half-life of 17 h for the ANP transcript was obtained in the absence ofthe steroid. The half-life appeared to increase to 30 h in the presence of Dex, suggesting a posttranscriptional effect; however, the difference failed to reach statistical significance.
Since our primary cultures obviously represent a mixed population of cells, it is conceivable that Dex could increase ANP mRNA levels by recruiting nonexpressing myocardial cells into the expressing pool. To address this question we have employed the technique of in situ hybridization. As shown in Fig. 4 of Dex on the processing ofproANP to ANP as a contributant to the increase in media ANP immunoreactivity. Thus, it is conceivable that the increase in ANP secretion noted in Table  I could reflect a combination of increased synthesis as well as increased processing of proANP to more immunoreactive forms. Matsubara et al. recently reported that Dex increased release of immunoreactive ANP from primary cultures of atrial (36) as well as ventricular (37) cells, although the latter appeared to be more sensitive to the steroid. The dose-response relationship of ANP release to Dex concentration in our studies resembles that of the ventricular cultures described by Matsubara (36, 37) with a half-maximal response at 10-8 M Dex.
The increase in rANP mRNA accumulation between 10-8 and 10-6 M is compatible with the known K of Dex for the glucocorticoid receptor (Kd 10-8 M at 370C) and is consistent with the dose-response relationship of Dex for biological effects in other systems (37) . The fact that ventricular ANP gene expression was sensitive to glucocorticoid stimulation substantiates results previously reported with in vivo studies (22, 23) where Dex administration to intact rats increased both atrial and ventricular ANP mRNA levels and suggests that glucocorticoid sensitivity is intrinsic to the gene itself and not confined to individual tissues.
The increase in ANP transcript levels resulted, at least in part, from an increase in the relative transcription rate of the ANP gene (Fig. 4 A) . Glucocorticoids are known to activate transcription in a number of systems (39- The role of glucocorticoid regulation of ANP genetic expression in the intact animal is not well understood. We have reported previously that large doses of Dex increase ANP mRNA levels in both atrial and extraatrial tissues in vivo (22) , an effect that may be related to the prominent natriuretic properties of similar doses of the steroid (20) . Others have reported increased circulating levels of ANP following administration of more physiological doses ofglucocorticoids in vivo (21) . Glucocorticoids are known to be required for normal vascular reactivity (18) and the maintenance of glomerular filtration (19) , two loci where ANP has well-described activity (1, 2) . Thus, it is possible that ANP may play an intermediary role in mediating or modulating some ofthe known cardiovascular effects of these steroids.
